Makale detayı · 2022 · article
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)
Dergi
J Cancer Res Clin Oncol
ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
ISSN0171-5216
YÖKSİS
OpenAlex
Açık erişim · green
Yıl2022
Atıf5OpenAlex
Atıf5Semantic Scholar
Yüzdelik%65,5
FWCI0,551,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q2
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıJ Cancer Res Clin Oncol
- Katalog eşleşmesi (ISSN)Journal of Cancer Research and Clinical Oncology
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
5atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 8 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2024 Is the percentage of hormone receptor positivity in HR+HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?Atıf 4 · OpenAlex
- 2024 Is the percentage of hormone receptor positivity in HR+ HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?Atıf 4 · OpenAlex
- 2024 Is the percentage of hormone receptor positivity in HR+ HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?Atıf 4 · OpenAlex
- 2026 Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study)Atıf 0 · OpenAlex
- 2023 Issues with the targeted therapy of non‑small cell lung cancer with thyroid metastases: A case reportAtıf 0 · OpenAlex
- 2023 Issues with the targeted therapy of non‑small cell lung cancer with thyroid metastases: A case reportAtıf 0 · OpenAlex
- 2023 Issues with the targeted therapy of non‑small cell lung cancer with thyroid metastases: A case reportAtıf 0 · OpenAlex
- 2023 Issues with the targeted therapy of non‑small cell lung cancer with thyroid metastases: A case reportAtıf 0 · OpenAlex